Latest AI and machine learning research in other cancers for healthcare professionals.
BACKGROUND: Metabolic reprogramming is a hallmark of cancer. However, the precise mechanisms by which specific metabolic pathways drive prostate cancer (PCa) progression and shape the tumor microenvironment remain poorly defined. METHODS: A machine learning-derived Metabolic Dysfunction Signature (MODS) was developed and validated as a prognostic model. Its clinical relevance was established throu...
Hepatocellular carcinoma remains a leading cause of cancer mortality worldwide, with peritumoral microenvironment interactions playing a critical role in disease progression. This multi-omics study employed artificial intelligence-pathology, single-nucleus multi-omics, spatial transcriptomics, and metabolomics to characterize peritumoral ductular reactions. Ductular reaction scores strongly predic...
Di-(2-ethylhexyl) terephthalate (DOTP), as an alternative to phthalate plasticizers, has been widely used in sensitive fields such as food packaging a...
INTRODUCTION: This study aimed to develop and validate a machine learning model that integrates radiomic features from 2-[18F]fluoro-2-deoxy-D-glucose...
BACKGROUND: Pathological reports provide comprehensive insights into the clinical and pathological features of different cancer types. However, extrac...
RATIONALE AND OBJECTIVES: To develop a cluster-specific magnetic resonance (MR) radiomics model for predicting induction chemotherapy (ICT) response i...
RATIONALE AND OBJECTIVES: Predicting neoadjuvant chemotherapy (NACT) efficacy is vital for advanced nasopharyngeal carcinoma (LA-NPC) management. Exis...
UNLABELLED: Deep learning (DL) has the potential to enable the prediction of gene mutations directly from routine histopathology slides in lung cancer...
UNLABELLED: Circular RNAs (circRNA) are associated with crucial hallmarks of tumorigenesis. Select circRNAs contain circular open reading frames (cORF...
UNLABELLED: Multiplexed imaging of tissues is an approach that holds promise for improving early detection, diagnosis, and treatment of cancer. In thi...
PURPOSE: The benefit of treatment intensification in metastatic colorectal cancer (mCRC) may be influenced by host-related factors that are not accoun...
AI-ML approaches emerged as transformative technologies in cancer drug discovery by accelerating the target identification and lead optimization. EGFR...
OBJECTIVE: This study addresses maxillary deficiency management by developing a deep learning-based system for zygomaticomaxillary suture assessment. ...
Colorectal liver metastases (CRLM) represent a major clinical challenge because outcomes after hepatic resection vary widely between patients. Preoper...
OBJECTIVES: To develop and validate an integrated clinical-radiomics nomogram predicting the risk of metachronous liver metastasis (MLM) in patients w...
PURPOSE: Early-stage lung adenocarcinoma (LUAD) exhibits substantial clinical heterogeneity that is not fully explained by TNM staging, highlighting t...
PURPOSE: To develop and validate machine learning (ML) models for postoperative risk stratification in oral cavity squamous cell carcinoma (OCSCC) and...
Bone tumors such as osteosarcoma and Ewing sarcoma remain among the most challenging cancers to diagnose and monitor because of their biological heter...
Colorectal cancer (CRC) is one of the most common causes of cancer mortality globally. Analysis of immune cell infiltration patterns in the tumour mic...
Therapeutic efficacy for malignancies and neurological disorders is fundamentally restricted by biological barriers, particularly the complex tumor mi...